First Time Loading...

Ambuja Cements Ltd
NSE:AMBUJACEM

Watchlist Manager
Ambuja Cements Ltd Logo
Ambuja Cements Ltd
NSE:AMBUJACEM
Watchlist
Price: 619.6 INR 0.68% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

331.6B
+3%
Revenue
Growth Rates:
1 Year
-15%
3 Years
+28%
5 Years
+26%
7 Years
+42%
10 Years
-
47.8B
+12%
Operating Income
Growth Rates:
1 Year
+36%
3 Years
+6%
5 Years
+67%
7 Years
+164%
10 Years
-
35.8B
+13%
Net Income
Growth Rates:
1 Year
+38%
3 Years
+30%
5 Years
+57%
7 Years
+192%
10 Years
-

Earnings Waterfall
Ambuja Cements Ltd

Revenue
331.6B INR
Cost of Revenue
-130.3B INR
Gross Profit
201.3B INR
Operating Expenses
-153.5B INR
Operating Income
47.8B INR
Other Expenses
-12B INR
Net Income
35.8B INR

Income Statement
Ambuja Cements Ltd

Rotate your device to view
Income Statement
Currency: INR
Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Sep-2006 Dec-2006 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
22 487
N/A
25 883
+15%
30 797
+19%
30 513
-1%
31 075
+2%
31 985
+3%
28 118
-12%
38 753
+38%
60 706
+57%
122 348
+102%
173 570
+42%
229 311
+32%
233 922
+2%
244 354
+4%
246 923
+1%
252 881
+2%
252 191
0%
248 468
-1%
254 853
+3%
260 409
+2%
264 121
+1%
266 511
+1%
267 111
+0%
271 036
+1%
265 278
-2%
240 979
-9%
241 898
+0%
245 162
+1%
259 814
+6%
283 154
+9%
287 931
+2%
289 655
+1%
291 507
+1%
302 053
+4%
307 014
+2%
309 828
+1%
389 370
+26%
317 170
-19%
319 978
+1%
322 199
+1%
331 596
+3%
Gross Profit
Cost of Revenue
(8 214)
(9 674)
(9 457)
(9 634)
(9 393)
(9 004)
(7 037)
(9 248)
(23 943)
(48 181)
(68 630)
(109 361)
(94 493)
(98 232)
(96 309)
(112 772)
(88 654)
(82 210)
(84 197)
(108 398)
(90 976)
(92 719)
(91 531)
(114 244)
(88 983)
(80 524)
(80 590)
(96 052)
(84 463)
(90 075)
(92 041)
(119 132)
(103 801)
(117 212)
(129 717)
(134 864)
(196 135)
(138 311)
(133 414)
(128 142)
(130 321)
Gross Profit
14 272
N/A
16 208
+14%
21 339
+32%
20 879
-2%
21 682
+4%
22 981
+6%
21 081
-8%
29 505
+40%
36 763
+25%
74 167
+102%
104 940
+41%
119 950
+14%
139 429
+16%
146 122
+5%
150 614
+3%
140 109
-7%
163 537
+17%
166 258
+2%
170 656
+3%
152 011
-11%
173 145
+14%
173 792
+0%
175 580
+1%
156 792
-11%
176 294
+12%
160 454
-9%
161 307
+1%
149 110
-8%
175 351
+18%
193 079
+10%
195 890
+1%
170 522
-13%
187 706
+10%
184 842
-2%
177 296
-4%
174 964
-1%
193 235
+10%
178 860
-7%
186 564
+4%
194 057
+4%
201 276
+4%
Operating Income
Operating Expenses
(8 176)
(9 630)
(15 382)
(14 981)
(15 274)
(15 315)
(13 149)
(17 023)
(33 087)
(62 747)
(90 736)
(102 759)
(121 324)
(125 937)
(128 455)
(112 931)
(134 984)
(137 890)
(141 881)
(122 493)
(144 536)
(144 284)
(142 577)
(121 635)
(140 074)
(127 989)
(125 388)
(109 944)
(130 165)
(140 690)
(142 697)
(120 023)
(141 635)
(146 313)
(150 130)
(149 068)
(158 163)
(153 470)
(151 689)
(151 342)
(153 514)
Selling, General & Administrative
(3 404)
(4 122)
(7 035)
(6 956)
(7 087)
(7 318)
(6 541)
(5 908)
(17 635)
(34 229)
(48 879)
(77 078)
(66 566)
(70 006)
(73 174)
(90 855)
(80 844)
(84 343)
(87 012)
(100 652)
(88 619)
(86 697)
(86 572)
(100 476)
(85 030)
(77 807)
(77 214)
(88 635)
(80 822)
(87 266)
(87 955)
(100 276)
(85 858)
(88 710)
(90 154)
(90 306)
(130 137)
(93 345)
(92 859)
(92 698)
(93 534)
Depreciation & Amortization
(2 474)
(2 638)
(2 196)
(2 084)
(1 994)
(1 929)
(1 520)
(1 778)
(5 281)
(8 216)
(11 354)
(14 609)
(12 455)
(12 596)
(12 429)
(12 195)
(11 950)
(11 735)
(11 638)
(11 539)
(11 454)
(11 376)
(11 349)
(11 525)
(11 694)
(11 832)
(11 886)
(11 618)
(11 343)
(11 192)
(11 054)
(11 525)
(11 892)
(12 310)
(12 853)
(12 923)
(16 447)
(13 921)
(14 423)
(15 227)
(16 234)
Other Operating Expenses
(2 298)
(2 870)
(6 152)
(5 940)
(6 192)
(6 067)
(5 088)
(9 336)
(10 172)
(20 304)
(30 503)
(11 072)
(42 303)
(43 335)
(42 852)
(9 882)
(42 190)
(41 813)
(43 231)
(10 302)
(44 464)
(46 211)
(44 656)
(9 634)
(43 352)
(38 351)
(36 289)
(9 691)
(38 002)
(42 235)
(43 689)
(8 222)
(43 885)
(45 294)
(47 124)
(45 838)
(11 579)
(46 204)
(44 407)
(43 418)
(43 746)
Operating Income
6 096
N/A
6 578
+8%
5 957
-9%
5 897
-1%
6 408
+9%
7 666
+20%
7 932
+3%
12 482
+57%
3 676
-71%
11 419
+211%
14 202
+24%
17 191
+21%
18 103
+5%
20 185
+12%
22 159
+10%
27 178
+23%
28 553
+5%
28 367
-1%
28 775
+1%
29 518
+3%
28 609
-3%
29 508
+3%
33 003
+12%
35 156
+7%
36 221
+3%
32 466
-10%
35 920
+11%
39 166
+9%
45 186
+15%
52 389
+16%
53 193
+2%
50 499
-5%
46 071
-9%
38 528
-16%
27 166
-29%
25 896
-5%
35 073
+35%
25 389
-28%
34 875
+37%
42 715
+22%
47 761
+12%
Pre-Tax Income
Interest Income Expense
(937)
(962)
(723)
(374)
(53)
321
543
360
(368)
(779)
(1 187)
4 246
(1 642)
(1 583)
(1 658)
2 529
(1 745)
(1 832)
(1 710)
2 585
(1 511)
(1 436)
(1 405)
5 235
(1 462)
(1 391)
(1 378)
3 750
(1 209)
(1 262)
(1 267)
3 083
(1 262)
(1 252)
(1 284)
(1 317)
5 620
(1 541)
(1 760)
(1 991)
(2 535)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
(386)
0
0
0
(22)
0
0
0
(1 572)
(1 518)
0
(1 518)
(215)
0
0
0
(2 004)
(1 760)
(1 760)
(1 760)
(1 096)
(1 205)
(1 205)
(1 519)
(1 719)
(3 174)
0
0
0
2 116
Total Other Income
998
781
947
713
299
183
0
0
1 665
3 002
3 972
(972)
3 760
3 236
2 991
(2 007)
3 343
3 350
3 425
(1 346)
5 477
5 761
6 086
(1 424)
4 599
4 603
4 449
(996)
4 050
3 715
3 681
(842)
3 456
4 010
4 092
4 546
(225)
7 777
11 521
12 160
11 664
Pre-Tax Income
6 157
N/A
6 397
+4%
6 181
-3%
6 236
+1%
6 654
+7%
8 170
+23%
8 474
+4%
12 842
+52%
4 974
-61%
13 644
+174%
16 989
+25%
20 078
+18%
20 222
+1%
21 838
+8%
23 493
+8%
27 677
+18%
30 151
+9%
29 886
-1%
30 489
+2%
29 185
-4%
31 057
+6%
33 832
+9%
36 166
+7%
38 753
+7%
39 358
+2%
35 679
-9%
38 992
+9%
39 916
+2%
46 266
+16%
53 082
+15%
53 845
+1%
51 645
-4%
47 060
-9%
40 082
-15%
28 455
-29%
27 406
-4%
37 295
+36%
31 625
-15%
44 637
+41%
52 884
+18%
59 006
+12%
Net Income
Tax Provision
(1 034)
(1 104)
(832)
(893)
(1 021)
(1 001)
(1 300)
(2 089)
(2 141)
(4 415)
(5 410)
(5 738)
(4 744)
(5 574)
(6 066)
(8 229)
(9 529)
(9 601)
(9 757)
542
479
(824)
(1 779)
(11 954)
(12 086)
(10 799)
(11 416)
(8 848)
(10 341)
(11 471)
(11 361)
(14 534)
(13 668)
(9 646)
(6 414)
(4 795)
(7 051)
(7 246)
(10 898)
(13 128)
(11 626)
Income from Continuing Operations
5 124
5 294
5 350
5 343
5 633
7 169
7 174
10 753
2 832
9 228
11 578
14 341
15 478
16 264
17 427
19 449
20 622
20 285
20 732
29 727
31 537
33 010
34 389
26 799
27 273
24 880
27 576
31 068
35 924
41 611
42 482
37 110
33 393
30 435
22 042
22 611
30 244
24 379
33 739
39 756
47 380
Income to Minority Interest
(331)
(397)
(169)
(91)
(70)
(5)
(3)
(1)
(1 159)
(2 387)
(2 836)
(3 290)
(3 185)
(3 587)
(4 045)
(4 285)
(4 476)
(4 435)
(4 611)
(7 953)
(8 707)
(9 206)
(9 611)
(6 882)
(6 766)
(6 032)
(6 361)
(7 414)
(8 341)
(9 832)
(10 263)
(9 307)
(8 472)
(6 762)
(4 095)
(3 226)
(4 410)
(3 598)
(5 960)
(8 090)
(11 612)
Equity Earnings Affiliates
0
0
0
0
0
0
0
0
43
68
61
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
4 793
N/A
4 897
+2%
5 181
+6%
5 252
+1%
5 564
+6%
7 165
+29%
7 172
+0%
10 999
+53%
1 717
-84%
6 910
+302%
8 804
+27%
11 051
+26%
12 248
+11%
12 608
+3%
13 320
+6%
15 164
+14%
16 148
+6%
15 850
-2%
16 121
+2%
21 774
+35%
22 829
+5%
23 803
+4%
24 777
+4%
20 950
-15%
21 538
+3%
19 880
-8%
22 247
+12%
23 654
+6%
27 583
+17%
31 779
+15%
32 219
+1%
27 804
-14%
24 920
-10%
23 673
-5%
17 947
-24%
19 385
+8%
25 834
+33%
20 781
-20%
27 779
+34%
31 666
+14%
35 768
+13%
EPS (Diluted)
3.54
N/A
3.46
-2%
4.01
+16%
3.9
-3%
4.1
+5%
5.26
+28%
5.29
+1%
4.75
-10%
1.11
-77%
4.46
+302%
4.43
-1%
5.56
+26%
6.17
+11%
6.35
+3%
6.71
+6%
7.64
+14%
8.12
+6%
7.97
-2%
8.11
+2%
10.96
+35%
11.49
+5%
11.98
+4%
12.47
+4%
10.54
-15%
10.83
+3%
10
-8%
11.19
+12%
11.91
+6%
13.88
+17%
15.99
+15%
16.21
+1%
14
-14%
12.54
-10%
11.92
-5%
9.04
-24%
9.56
+6%
12.64
+32%
9.89
-22%
13.1
+32%
14.85
+13%
16.67
+12%

See Also

Summary
AMBUJACEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMBUJACEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMBUJACEM stock valuation using valuation multiples.
Wall Street Estimates
AMBUJACEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMBUJACEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.